 Allscripts Healthcare Solutions Inc NASDAQ: MDRX expects Q4 revenue of 390 million - 395 million, better than the consensus of 386.75 million. For FY21, the Company expects GAAP operating income of 70 million - 75 million and adjusted EBITDA of 295 million - 300 million, an increase from the prior outlook of 275 million - 285 million. 